President and CEO of Novavax Inc (NVAX, Financial) Stanley C Erck bought 100,000 shares of NVAX on 05/14/2018 at an average price of $1.65 a share. The total cost of this purchase was $165,000.
Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. Novavax Inc has a market cap of $645.040 million; its shares were traded at around $1.69 with and P/S ratio of 14.81.
CEO Recent Trades:
- President and CEO Stanley C Erck bought 100,000 shares of NVAX stock on 05/14/2018 at the average price of $1.65. The price of the stock has increased by 2.42% since.
CFO Recent Trades:
- SVP, CBO and CFO John Trizzino bought 50,000 shares of NVAX stock on 05/14/2018 at the average price of $1.64. The price of the stock has increased by 3.05% since.
Directors and Officers Recent Trades:
- President, R&D Gregory M Glenn bought 20,000 shares of NVAX stock on 05/14/2018 at the average price of $1.64. The price of the stock has increased by 3.05% since.
For the complete insider trading history of NVAX, click here
.
